Company / Gross Profit per Share
AVADEL PHARMACEUTICALS PLC Gross Profit per Share History
FY2021-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit per Share
$1.62
FY2024
5-year range
$0.00 / $1.62
FY2021-FY2024
Trend
+378.1%
vs FY2023
Sector context
#23 of 29
Health Care
What the data says
AVADEL PHARMACEUTICALS PLC's gross profit per share of $1.62 is lower than 79% of companies in the Health Care sector (FY2024). Improved from $0.00 to $1.62 over the past 2 years.
Based on SEC 10-K filings.
1.62 in FY2024.
Improved from $0.00 to $1.62 over the past 2 years.
Health Care sector context is included.
Gross Profit per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 21% in Health CareTop 79% of 29This company $1.62 Sector average $8.10
▼
-80.0% below sector average
Key checks
Key Insights
- In FY2024, gross profit per share increased 378.1% year-over-year.
- Ranks #23 out of 29 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.94 (distress zone, below 1.8 threshold)
- Negative profit margin: -28.9%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross Profit per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $1.62 | +378.1% |
| FY2023 | $0.34 | - |
| FY2022 | $0.00 | - |
| FY2021 | $0.00 | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
| FY2015 | - | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026